title: FDA is urged to reverse its approval of new pain drug Zohydro ER.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology; D003692:Delayed-Action Preparations; D017277:Drug Approval; D006801:Humans; D006853:Hydrocodone / Q000494:pharmacology*; D010146:Pain / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D006853:Hydrocodone